本页面由Tiger Trade Technology Pte. Ltd.提供服务

Trevi Therapeutics Inc.

12.93
-0.2600-1.97%
盘前:12.980.0500+0.39%07:46 EDT
成交量:477.08万
成交额:6,185.48万
市值:18.36亿
市盈率:-36.75
高:13.46
开:13.14
低:12.81
收:13.19
52周最高:20.22
52周最低:9.28
股本:1.42亿
流通股本:1.18亿
量比:1.02
换手率:4.04%
股息:- -
股息率:- -
每股收益(TTM):-0.3518
每股收益(LYR):-0.3173
净资产收益率:-19.66%
总资产收益率:-13.82%
市净率:5.71
市盈率(LYR):-40.75

数据加载中...

2022/05/16

重要事件披露

8-K - Current report
2022/05/12

重要事件披露

8-K - Current report
2022/05/12

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/05/09

SEC问询函

CORRESP [Cover] - Correspondence
2022/05/02

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/04/25

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/04/21

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/04/21

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/04/18

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/04/08

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/04/07

重要事件披露

8-K - Current report
2022/03/17

重要事件披露

8-K - Current report
2022/03/17

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/03/16

重要事件披露

8-K - Current report
2022/03/09

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/03/09

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/24

重要事件披露

8-K - Current report
2022/02/14

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/01

重要事件披露

8-K - Current report